Qumis | $2,200,000 | (Jan 22, 2025)
Zynap | $5,937,902 | (Jan 22, 2025)
Belfry | $12,000,000 | (Jan 22, 2025)
Certified by Founder
Lodge
INNOVENTRIC
start up
Israel
- Rehovot
- 30/10/2024
- Series B
- $28,500,000
Innoventric is a Structural Heart medical device company specializing in the development of percutaneous heterotopic cross-caval solutions for Tricuspid Regurgitation and right heart disease.
http://www.innoventric.com
#TTVR #Cardiology #MedTech #InterventionalCardiology #heterotopic #crosscaval #medicaldevices
- Industry Medical Device
- Website https://innoventric.com/
- LinkedIn https://www.linkedin.com/company/innoventric/
Gravity(US) | $13,000,000 | (Jan 22, 2025)
LeapXpert | $20,000,000 | (Jan 22, 2025)
BPR Hub | $2,600,000 | (Jan 22, 2025)
NovoLINC | Undisclosed Amount | (Jan 22, 2025)
IntusCare | $11,500,000 | (Jan 21, 2025)
ecoplanet | $16,571,680 | (Jan 21, 2025)
Sereact | $25,894,660 | (Jan 21, 2025)
Fundment | $55,157,175 | (Jan 21, 2025)
Men In Blazers Media Network | $150,000,000 | (Jan 21, 2025)